TNFSF13B and acute lymphoblastic leukemia: Five T-ALL cell lines with normal (SUP-1, JURKAT) and silenced (LOUCY, DND-41, TALL-1) TET2 expression were treated with 5-aza for 72 h followed by a recovery period without treatment for 5 d (Fig. 3A).